Drug intelligence / Profile preview

gallium Ga-68 citrate

Development stage
Unknown
Lead developer
Rutgers University
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Gallium Ga-68 citrate is an investigational radiopharmaceutical being evaluated as a functional imaging agent for positron emission tomography (PET) in patients with hepatocellular carcinoma (HCC). Developed by Rutgers, The State University of New Jersey, it utilizes the positron-emitting isotope Gallium-68. Gallium ions (Ga3+) act as iron mimetics, binding to plasma transferrin and subsequently being internalized by cells via transferrin receptors, which are frequently upregulated in HCC. This mechanism allows for the visualization of intrahepatic lesions and potentially provides a more sensitive diagnostic tool compared to conventional CT or MRI for HCC detection and treatment monitoring.

Other names
68Gallium citrategallium-68 citrategallium68 citrategallium 68 citrate68Ga-citrate PET/CT
02

Targets

LTF (Lactoferrin)TFRC (Transferrin Receptor)

Beyond the preview

Go deeper on gallium Ga-68 citrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallium Ga-68 citrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call